The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Davis George Eric since year 2005.
The trader's CIK number is 1380710.
At the time of this reporting, Davis George Eric is the VP, General Counsel of Biomarin Pharmaceutical Inc .
(stock ticker symbol BMRN).
See this page for all insider trading activities at Biomarin Pharmaceutical Inc .
Stock purchases, sales, and option exercises reported by insider Davis George Eric since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-06-16
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
10,000
7.84
78,400
2008-05-13
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
10,000
11.74
117,400
2008-05-13
BMRN
Biomarin Pharmaceutical Inc
Sale
10,000
39.15
391,520
2008-04-30
BMRN
Biomarin Pharmaceutical Inc
Purchase
1,810
10.37
18,769
2008-04-30
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
5,000
7.84
39,200
2008-04-30
BMRN
Biomarin Pharmaceutical Inc
Sale
4,600
36.29
166,935
2008-04-30
BMRN
Biomarin Pharmaceutical Inc
Sale
400
36.73
14,693
2008-03-03
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
20,000
6.98
139,700
2008-03-03
BMRN
Biomarin Pharmaceutical Inc
Sale
20,000
38.00
760,000
2007-10-11
BMRN
Biomarin Pharmaceutical Inc
Sale
5,000
27.34
136,700
2007-10-11
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
5,000
8.05
40,250
2007-10-01
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
5,000
6.13
30,650
2007-10-01
BMRN
Biomarin Pharmaceutical Inc
Sale
5,000
25.10
125,500
2007-08-15
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
4,000
6.13
24,520
2007-08-15
BMRN
Biomarin Pharmaceutical Inc
Sale
4,000
20.26
81,040
2007-04-30
BMRN
Biomarin Pharmaceutical Inc
Purchase
2,607
5.18
13,517
2007-02-22
BMRN
Biomarin Pharmaceutical Inc
Sale
13,000
18.38
238,940
2007-02-22
BMRN
Biomarin Pharmaceutical Inc
Option Exercise
13,000
6.13
79,690
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Davis George Eric
(VP, General Counsel of Biomarin Pharmaceutical Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
